Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.3028
-0.0157 (-4.93%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Xtant Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 109.53 | 133.93 | 117.27 | 91.3 | 57.97 | 55.15 |
Other Revenue | - | - | - | - | - | 0.12 |
| 109.53 | 133.93 | 117.27 | 91.3 | 57.97 | 55.26 | |
Revenue Growth | -14.27% | 14.21% | 28.44% | 57.50% | 4.90% | 3.61% |
Cost of Revenue | 44.48 | 49.65 | 49.05 | 35.84 | 25.83 | 22.77 |
Gross Profit | 65.05 | 84.27 | 68.22 | 55.47 | 32.14 | 32.49 |
Selling, General & Admin | 68.32 | 74.89 | 77.91 | 64.29 | 37.98 | 34.87 |
Research & Development | 2.22 | 2.1 | 2.39 | 1.34 | 0.92 | 0.87 |
Operating Expenses | 70.54 | 76.99 | 80.29 | 65.63 | 38.89 | 35.74 |
Operating Income | -5.5 | 7.28 | -12.07 | -10.16 | -6.76 | -3.25 |
Interest Expense | -2.76 | -3.67 | -4.16 | -2.94 | -1.69 | -1 |
Interest & Investment Income | 0.31 | 0.09 | - | 0.15 | 0.03 | - |
Currency Exchange Gain (Loss) | -0.24 | -0.06 | 0.01 | 0.27 | - | - |
Other Non Operating Income (Expenses) | -4.34 | 0.07 | -0.03 | -0.05 | - | - |
EBT Excluding Unusual Items | -12.52 | 3.72 | -16.26 | -12.73 | -8.42 | -4.25 |
Gain (Loss) on Sale of Assets | 3.28 | 3.28 | - | - | - | - |
Legal Settlements | - | - | - | - | - | -0.6 |
Other Unusual Items | - | - | - | 11.69 | - | - |
Pretax Income | -9.24 | 7 | -16.26 | -1.04 | -8.42 | -4.85 |
Income Tax Expense | 1.9 | 2.03 | 0.19 | -1.7 | 0.07 | - |
Net Income | -11.14 | 4.97 | -16.45 | 0.66 | -8.49 | -4.85 |
Net Income to Common | -11.14 | 4.97 | -16.45 | 0.66 | -8.49 | -4.85 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 140 | 140 | 134 | 119 | 94 | 85 |
Shares Outstanding (Diluted) | 140 | 150 | 134 | 127 | 94 | 85 |
Shares Change | 1.38% | 12.25% | 5.42% | 34.76% | 10.10% | 199.85% |
EPS (Basic) | -0.08 | 0.04 | -0.12 | 0.01 | -0.09 | -0.06 |
EPS (Diluted) | -0.08 | 0.03 | -0.12 | 0.01 | -0.09 | -0.06 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.7 | 10.16 | -16.01 | -10.97 | -7.11 | -1.68 |
Free Cash Flow Per Share | -0.01 | 0.07 | -0.12 | -0.09 | -0.08 | -0.02 |
Gross Margin | 59.39% | 62.92% | 58.17% | 60.75% | 55.44% | 58.79% |
Operating Margin | -5.02% | 5.44% | -10.30% | -11.13% | -11.65% | -5.89% |
Profit Margin | -10.17% | 3.71% | -14.03% | 0.72% | -14.64% | -8.77% |
Free Cash Flow Margin | -0.64% | 7.59% | -13.65% | -12.02% | -12.26% | -3.03% |
EBITDA | -1.47 | 12.51 | -7.85 | -6.98 | -5.46 | -1.92 |
EBITDA Margin | -1.34% | 9.34% | -6.69% | -7.65% | -9.42% | -3.48% |
D&A For EBITDA | 4.02 | 5.22 | 4.22 | 3.17 | 1.29 | 1.33 |
EBIT | -5.5 | 7.28 | -12.07 | -10.16 | -6.76 | -3.25 |
EBIT Margin | -5.02% | 5.44% | -10.30% | -11.13% | -11.65% | -5.89% |
Effective Tax Rate | - | 28.97% | - | - | - | - |
Revenue as Reported | 109.53 | 133.93 | 117.27 | 91.3 | - | 55.26 |